ST Pharm Announces RNA Symposium on September 8
World-renowned scholars in the field of RNA, including a Nobel laureate in Physiology or Medicine, will gather in Seoul to discuss the future of next-generation therapeutics.ST Pharm announced on August 18 that it will hold the international symposium for RNA innovation, ‘RISC 2026 (RNA Innovation S
ST Pharm has announced the upcoming RNA symposium, 'RISC 2026 (RNA Innovation Symposium Corea 2026),' which will take place on September 8 at El Tower in Yangjae, Seocho-gu, Seoul. The event, the second international symposium in ST Pharm's RISC series, aims to share the latest research achievements and industry trends in the RNA therapeutics sector, as well as to foster collaborations among global industry, academia, and research institutes.
Notable speakers include Nobel laureate Professor Craig Mello and industry experts such as John Maraganore, CEO of Coresa, and Muthiah Manoharan, Distinguished Scientist at Alnylam Pharmaceuticals. The symposium will cover core technology trends in next-generation RNA therapeutics, including mRNA, antisense oligonucleotides (ASO), and small interfering RNA (siRNA).
ST Pharm plans to use this event to strengthen its research and development and production capabilities while expanding the global open innovation ecosystem in the RNA therapeutics industry.
Brief written by urgent.news from BusinessKorea's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
